• This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • #5530

    The National Cancer Institute’s (NCI) analysis of the company’s COVID-19 IgG/IgM Rapid Test reported 100% combined sensitivity and 97.5% combined specificity for the lateral flow immunoassay.

    More Information

Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.